首页 | 本学科首页   官方微博 | 高级检索  
检索        

盐酸文拉法辛合并舒肝解郁胶囊与多虑平治疗躯体形式障碍的对照研究
引用本文:赵云,单敬,贾会珍,柴瑞莉,田晓锦.盐酸文拉法辛合并舒肝解郁胶囊与多虑平治疗躯体形式障碍的对照研究[J].中国健康心理学杂志,2011(11):1312-1314.
作者姓名:赵云  单敬  贾会珍  柴瑞莉  田晓锦
作者单位:河北省衡水市哈励逊国际和平医院心理门诊;
基金项目:2007年衡水市科学技术研究与发展指导计划项目(编号:07027z)
摘    要:目的探讨盐酸文拉法辛合并舒肝解郁胶囊对躯体形式障碍的疗效、不良反应和依从性。方法采用随机分组的方法,将156例躯体形式障碍患者分为治疗组77例,对照组79例,治疗8周,用症状自评量表(SCL-90)和副反应量表(TESS)评定疗效和不良反应。结果治疗组与对照组比较躯体形式障碍的起效时间有统计学意义(t=2.71,P<0.05),不良反应方面有显著性差异(χ2=49.01,P<0.01),依从性有显著差异(χ2=6.62,P<0.01)。结论盐酸文拉法辛合并舒肝解郁胶囊与多虑平比较对躯体形式障碍起效快,不良反应小、依从性好,值得临床应用和推广。

关 键 词:盐酸文拉法辛  舒肝解郁胶囊  多虑平  躯体形式障碍

Comparative Study on Venlafaxine Combined Shuganjieyu Capsule with Doxepin in the Treatment of Somatoform Disorders
Zhao Yun,Shan Jing,Jia Huizhen,et al..Comparative Study on Venlafaxine Combined Shuganjieyu Capsule with Doxepin in the Treatment of Somatoform Disorders[J].china journal of health psychology,2011(11):1312-1314.
Authors:Zhao Yun  Shan Jing  Jia Huizhen  
Institution:Zhao Yun,Shan Jing,Jia Huizhen,et al.Harison International Peace Hospital of Hengshui,Hengshui 053000,P.R.China
Abstract:Objective To study the clinical effects,side effects and compliance of venlafaxine combined Shuganjieyu capsule in treatment of somatoform disorders.Methods A total of 156 patients who met CCMD-3 for somatoform disorders were randomly divided into venlafaxine(77 patients) and doxepin(79patients) group,and treated for 8 weeks.The clinical effects and side effects were tested with SCL-90 and TESS.Results The clinical effect of venlafaxine was significant difference to doxepin(t=2.71,P<0.05).The venlafaxine ha...
Keywords:Venlafaxine  Shuganjieyu capsule  Doxepin  Somatoform disorders  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号